– Mike Kaufmann retires as CEO and board member –
– Jason Hollar, Chief Financial Officer, appointed CEO –
– Patricia English to act as interim financial director –
, / PRNewswire / – Cardinal Health (NYSE: CAH) announced today that its board has elected Jason Hollar as the company’s new CEO effective September 1, 2022. Hollar will also join the board from August 11, 2022. Hollar will replace current CEO Mike and Kaufmann.
Hollar, an experienced CFO and Operations Officer, has served as CFO of Cardinal Health since May 2020, conducting corporate-wide financial activities including financial strategy, capital implementation, treasury, tax, investor relations, risk management, accounting and reporting. During his tenure, he helped Cardinal Health prioritize investment in growing businesses, strengthen its balance sheet, and return capital to shareholders. Prior to joining Cardinal Health, Hollar served as Tenneco’s chief financial officer and executive vice president. Previously, Hollar served as chief financial officer and senior vice president of finance for Sears Holdings Corporation.
In addition, Patricia English will be serving as Cardinal Health’s Interim CFO, working with Hollar to ensure a smooth transition. English currently serves as Chief Accountant and Senior Vice President of Cardinal Health, and previously served as Vice President of Accounting in both the Pharmaceutical and Medical segments. Cardinal Health’s board of directors will engage an executive search firm to evaluate candidates for the position of permanent chief financial officer.
“Mike has been a great leader during his tenure at Cardinal Health, helping the company through a period of unprecedented challenges, driving strategic investments for growth and innovation, and cultivating an inclusive and dynamic workforce culture. We are grateful for Mike’s many contributions to his more than 30 years of service and wish him the best in his future endeavors, ”said Gregory Kenny, independent chairman of the board of Cardinal Health. “We look forward to leveraging Jason’s extensive executive experience, and we are confident that he is able to lead Cardinal Health on a long-term growth path.”
Kaufmann said, “I am grateful for the privilege of serving with such a dedicated, goal-oriented and talented team for the past three decades. It has truly been a lifetime honor to serve as CEO of Cardinal Health for the past five years. The Board and I believe that Jason is the right person to lead Cardinal Health in the years to come.
Hollar said: “I sincerely appreciate the trust management has placed in me to help position the company for future growth. This is a transformation period for Cardinal Health and I am humble to have the opportunity to run a company that plays such a vital role in the healthcare ecosystem. I look forward to working closely with Cardinal Health’s talented people, management team and board of directors as we continue to build on our strong foundations and deliver value to our customers, communities and shareholders.
Hollar continued: “I am also looking forward to continuing to work with Trish, who has been a valuable member of the Cardinal Health family for over sixteen years. He brings a strong combination of financial expertise and leadership experience to the role of interim finance director. “
About Jason Hollar Jason Hollar has been CFO of Cardinal Health since May 2020, leading corporate-wide financial activities including financial strategy, capital implementation, treasury, tax, investor relations, accounting and reporting. Hollar has extensive management experience as well as experience in dynamic environments, most recently serving as CFO of Tenneco Inc., a global automotive products and services company. As an executive vice president and chief financial officer of Tenneco, Hollar was responsible for financial planning and analysis, accounting and reporting, taxation, treasury and investor relations for the company. Hollar joined Tenneco in June 2017 from Sears Holdings Corporation, where he served as chief financial officer and senior vice president of finance. Prior to joining Sears, Hollar worked at both Delphi Automotive and Navistar International in a number of senior finance roles. He served as Delphi’s corporate controller and vice president of finance in the company’s propulsion systems division, which also oversaw the regions of Europe, the Middle East and Africa. At Navistar, he has held finance positions with increasing responsibility in the company’s engine group, South American operations, and corporate financial planning and analysis. Hollar holds a Master of Business Administration from the University of Chicago and a BA in Business from Indiana University.
About Patricia English Patricia English was the Chief Accountant and Senior Vice President of Cardinal Health from September 2020. Previously, she was the Vice President of Pharmaceutical Segment Accounting at Cardinal Health from January 2019 to August 2020. She also served as Vice President of the Medical Accounting Segment from March 2015 until December 2018 and as Director of Pharmaceutical Distribution Accounting from June 2011 to March 2015. English holds a BA in Accounting from Ohio State University.
WebcastCardinal Health will be broadcasting online today at 8:30 a.m. EST to discuss fourth-quarter and full-year results. To access the webcast and the corresponding slide presentation, please visit the Investor Relations page at ir.cardinalhealth.com. No access code is required. Presentation slides and webcast replay will be available until August 10, 2023.
About Cardinal HealthCardinal Health is a pharmaceutical distributor, global manufacturer and distributor of medical and laboratory products, and provider of performance and data solutions for healthcare facilities. With 50 years of operation, operations in more than 30 countries and approximately 44,000 employees worldwide, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.
Contacts Media: Erich Timmerman, [email protected] and 614.757.8231 Investors: Kevin Moran, [email protected] and 614.757.7942
Cautions Regarding Forward-Looking Statements This announcement contains forward-looking statements regarding expectations, prospects, estimates and other matters that depend on future events or developments. These statements can be identified by words such as “expect”, “anticipate”, “intend”, “plan”, “believe”, “will”, “should”, “might”, “would”, “design”, ” continue, “likely” and similar phrases, and include statements that reflect future performance or guidance, forward-looking statements, and various accruals and estimates. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated or implied.
Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those stated or implied by the forward-looking statements. All forward-looking statements should be made in the light of these risks, uncertainties and other factors, including those disclosed in “Risk Factors” in the Company’s most recent annual report on Form 10-K and as modified by Forms 10-Q and 8-Ks. All forward-looking statements are fully governed by these and other notices made by the Company from time to time in its filings with the SEC and in public announcements. The Company does not undertake, and in particular waives any obligation, to update or revise any forward-looking statements as a result of new information, future events or circumstances or otherwise, unless otherwise provided by law. Due to the above risks and uncertainties, readers are cautioned not to rely unduly on any forward-looking statements contained herein or which may be made elsewhere by or on behalf of the Company from time to time.
